SM, R., MS, L., KL, C., Y, Z., KN, K., A, K., . . . C, H. (2022). Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression. Frontiers in oncology, 12, 917834. https://doi.org/10.3389/fonc.2022.917834
Chicago Style (17th ed.) CitationSM, Rittig, et al. "Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression." Frontiers in Oncology 12 (2022): 917834. https://doi.org/10.3389/fonc.2022.917834.
MLA (9th ed.) CitationSM, Rittig, et al. "Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression." Frontiers in Oncology, vol. 12, 2022, p. 917834, https://doi.org/10.3389/fonc.2022.917834.
Warning: These citations may not always be 100% accurate.